COVID Resource Center Newsroom

Mayo Clinic has launched a new SARS-CoV-2 neutralizing antibody test in support of the nationwide convalescent plasma exchange study and other critical research efforts to establish effective therapies and vaccines for COVID-19. The test will be available through Mayo Clinic Laboratories to select labs, blood banks, and biopharma clients in late June.

Mayo Clinic Laboratories is now offering a new serology test with Emergency Use Authorization (EUA). This test is used to identify the presence of an immune response to SARS-CoV-2, the virus that causes COVID-19.

Antibody Test Kit from Thermo Fisher, WuXi, and Mayo Clinic This morning, Thermo Fisher Scientific Inc. announced it will expand its response to the COVID-19 pandemic[...]

Mayo Clinic partners with state of Minnesota and University of Minnesota on breakthrough COVID-19 initiative Mayo Clinic joined Minnesota Governor Tim Walz, Department of Health[...]

Mayo Clinic Laboratories expands COVID-19 testing to all U.S. Mayo Clinic Laboratories clients Since launching its test to aid in the diagnosis of COVID-19 infection,[...]

Mayo Clinic Laboratories launches serology testing in support of COVID-19 response A new serology test from Mayo Clinic Laboratories used to identify the presence of[...]